Physician profile

Dean B Asher

Diagnostic Radiology · Mobile, AL

NPI 1700856192

$2,068.60

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,594.07
Food and Beverage$330.30

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Philips North America LLC $1,885.94 2023
Genentech USA, INC. $70.70 2019
Stryker Corporation $25.00 2020
Novartis Pharmaceuticals Corporation $21.58 2023
Ge Healthcare $18.78 2021
Sirtex Medical INC $16.85 2024 Lava Les (Liquid Embolic System)
Abiomed $16.37 2019
Pharmacyclics LLC, An Abbvie Company $13.38 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dean B Asher

$2,068.60

in general payments reported 2019-2025

Years
2019-2024
Top company
Philips North America LLC

https://glasscript.com/doctor/1009773/dean-b-asher

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.